Ligand Based Design, ADMET and Molecular Docking Studies of Arylpiperazine Derivatives as Potent Anti-Proliferate Agents Against LNCAP Prostate Cancer Cell Lines
Crossref DOI link: https://doi.org/10.1007/s42250-020-00210-y
Published Online: 2021-01-03
Published Print: 2021-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ikwu, Fabian A. http://orcid.org/0000-0001-9937-0690
Shallangwa, Gideon A.
Mamza, Paul A.
Text and Data Mining valid from 2021-01-03
Version of Record valid from 2021-01-03
Article History
Received: 28 August 2020
Accepted: 18 November 2020
First Online: 3 January 2021
Compliance with Ethical Standards
:
: The Authors have no conflicts of interest/competing interests to report.